Works matching IS 00070963 AND DT 2021 AND VI 185 AND IP 2


Results: 94
    1

    Issue Information.

    Published in:
    British Journal of Dermatology, 2021, v. 185, n. 2, p. i, doi. 10.1111/bjd.20472
    Publication type:
    Article
    2

    News and Notices.

    Published in:
    British Journal of Dermatology, 2021, v. 185, n. 2, p. 472, doi. 10.1111/bjd.20650
    Publication type:
    Article
    3

    Editor's Choice.

    Published in:
    British Journal of Dermatology, 2021, v. 185, n. 2, p. ix, doi. 10.1111/bjd.20560
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Tildrakizumab: interpreting the data.

    Published in:
    British Journal of Dermatology, 2021, v. 185, n. 2, p. 242, doi. 10.1111/bjd.20430
    By:
    • Purvis, C.G.;
    • Emmerich, V.K.;
    • Feldman, S.R.
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49

    Pernio after COVID‐19 vaccination.

    Published in:
    British Journal of Dermatology, 2021, v. 185, n. 2, p. 445, doi. 10.1111/bjd.20404
    By:
    • Lopez, S.;
    • Vakharia, P.;
    • Vandergriff, T.;
    • Freeman, E.E.;
    • Vasquez, R.
    Publication type:
    Article
    50

    Antiracism plan in dermatology.

    Published in:
    British Journal of Dermatology, 2021, v. 185, n. 2, p. 428, doi. 10.1111/bjd.20390
    By:
    • Ortiz, C.;
    • Herman, E.;
    • James, A.J.
    Publication type:
    Article